Development and Pilot Testing of an Experimental Cannabis Marketplace: Toward Evaluating the Impact of Cannabis Policy on Consumer Choices
Cannabis and Cannabinoid Research · 2024
DOI: 10.1089/can.2022.0273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cannabis and Cannabinoid Research, 2024. Verfasst von Lara N Coughlin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Cannabis, Choice Behavior, Consumer Behavior. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
- Injury Prevention Center, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Lara N Coughlin
Zitieren
APA
Coughlin, L. N., Jennings, C. J., Hellman, L., Florimbio, A. R., Jannausch, M., & Bonar, E. E. (2024). Development and Pilot Testing of an Experimental Cannabis Marketplace: Toward Evaluating the Impact of Cannabis Policy on Consumer Choices. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2022.0273
Vancouver
Coughlin LN, Jennings CJ, Hellman L, Florimbio AR, Jannausch M, Bonar EE. Development and Pilot Testing of an Experimental Cannabis Marketplace: Toward Evaluating the Impact of Cannabis Policy on Consumer Choices. Cannabis and Cannabinoid Research. 2024. doi:10.1089/can.2022.0273
BibTeX
@article{Coughlin2024,
author = {Coughlin, Lara N and Jennings, Claudia J and Hellman, Lauren and Florimbio, Autumn Rae and Jannausch, Mary and Bonar, Erin E},
title = {Development and Pilot Testing of an Experimental Cannabis Marketplace: Toward Evaluating the Impact of Cannabis Policy on Consumer Choices},
journal = {Cannabis and Cannabinoid Research},
year = {2024},
doi = {10.1089/can.2022.0273}
}
EUVIMED